Rosu, M.C.; Tarta, C.; Moldovan, S.; Neamtu, A.-A.; Ardelean, A.; Capitanio, M.; Herczeg, D.; Faur, I.-F.; Bende, R.; Pilat, L.;
et al. Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study. Biomedicines 2025, 13, 928.
https://doi.org/10.3390/biomedicines13040928
AMA Style
Rosu MC, Tarta C, Moldovan S, Neamtu A-A, Ardelean A, Capitanio M, Herczeg D, Faur I-F, Bende R, Pilat L,
et al. Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study. Biomedicines. 2025; 13(4):928.
https://doi.org/10.3390/biomedicines13040928
Chicago/Turabian Style
Rosu, Mihai Catalin, Cristi Tarta, Silviu Moldovan, Andreea-Adriana Neamtu, Andrei Ardelean, Marco Capitanio, Diana Herczeg, Ionut-Flaviu Faur, Renata Bende, Luminita Pilat,
and et al. 2025. "Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study" Biomedicines 13, no. 4: 928.
https://doi.org/10.3390/biomedicines13040928
APA Style
Rosu, M. C., Tarta, C., Moldovan, S., Neamtu, A.-A., Ardelean, A., Capitanio, M., Herczeg, D., Faur, I.-F., Bende, R., Pilat, L., Prunoiu, V. M., Neamtu, C., & Totolici, B. D.
(2025). Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study. Biomedicines, 13(4), 928.
https://doi.org/10.3390/biomedicines13040928
